Regeneron Pharmaceuticals, Inc. (REGN)
698.25
-14.62
(-2.05%)
USD |
NASDAQ |
May 15, 16:00
698.50
+0.25
(+0.04%)
After-Hours: 20:00
Regeneron Pharmaceuticals Research and Development Expense (Quarterly) : 1.420B for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.719B |
| AbbVie, Inc. | 2.472B |
| Biogen, Inc. | 471.10M |
| Eli Lilly & Co. | 3.51B |
| Merck & Co., Inc. | 11.98B |